Including Traditional Chinese Medicine Diagnoses in ICD-11 May Not Advance the Evaluation of Traditional Chinese Medicine Therapies Stewart Geary Commentary 21 August 2019 Pages: 369 - 371
ICD-11: Impact on Traditional Chinese Medicine and World Healthcare Systems Wai Ching LamAiping LyuZhaoxiang Bian Current Opinion 26 July 2019 Pages: 373 - 377
Design and Analysis of Biosimilar Switching Studies Shein-Chung ChowSang Joon Lee Leading Article 20 August 2019 Pages: 379 - 388
Liver Test Monitoring: Real-World Compliance for Drugs with Monitoring Requirements at 2-Week Intervals or More Frequently Marsha A. WilcoxJill HardinErica A. Voss Short Communication Open access 08 August 2019 Pages: 389 - 394
Effectiveness of Risk Minimization Measures to Prevent Pregnancy Exposure to Mycophenolate-Containing Medicines in Europe Terri MadisonBarbara DonnerGiuseppe Alvaro Original Research Article 28 September 2019 Pages: 395 - 406
Ethnicity-Specific Drug Safety Data in European Medicines Agency Registration Dossiers, European Public Assessment Reports, and European and Singapore Drug Labels: Lost in Translation? Marc MaliepaardAnne C. TaamsYang Yu Original Research Article Open access 05 September 2019 Pages: 407 - 416
Evaluation of the Implementation of Additional Risk Minimization Activities in Europe, the USA, and Japan Yuka YasuokaMasayuki KanekoMamoru Narukawa Original Research Article 21 September 2019 Pages: 417 - 424